Condition: Locally Advanced Gastric Cancer · Sponsor: Guihua Wang
We plan to evaluate the efficacy and safety of proximal gastric vs. total gastric radical resection after SOX combined with anti-PD-1 neoadjuvant therapy in locally advanced upper gastric cancer
This description comes directly from the study's public registry record.
Guihua Wang · +86-027-83665215 · ghwang@tjh.tjmu.edu.cn
lisheng chen · +86-13797056427 · clsmail1990@163.com
Always discuss trial participation with your own doctor first.
| Tongji Hospital, Huazhong University of Science and Technology | Wuhan, Hubei, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06597227